1. Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université de Paris, FACT (French Alliance for Cardiovascular Trials), INSERM U1148, Paris, France (P.G.S.).
2. National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, United Kingdom (P.G.S.).
3. State University of New York, Downstate School of Public Health, Brooklyn (M.S.).
4. Brigham and Women’s Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA (D.L.B.).
5. Division of Cardiovascular Disease, University of Alabama at Birmingham. (V.A.B.).
6. Sanofi, Paris, France (M.F.B., C.H., G.L.).
7. Milpark Hospital, Johannesburg, Republic of South Africa (A.J.D.).
8. Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Argentina (R.D.).
9. Sanofi, Bridgewater, NJ (J.M.E., A.M.).
10. Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada and St. Michael’s Hospital, University of Toronto, Canada (S.G.G.).
11. Stanford Center for Clinical Research, Department of Medicine, Stanford University, CA (R.A.H., K.W.M.).
12. Department of Cardiology, Leiden University Medical Center, the Netherlands (J.W.J.).
13. Na Homolce Hospital, Prague, Czech Republic (P.O.).
14. Institute of Cardiology, Kyiv, Ukraine (A.P.).
15. Regeneron Pharmaceuticals Inc, Tarrytown, NY (R.P.).
16. Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (M.T.R., P.T.).
17. Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC (M.T.R.).
18. University of Colorado Denver (R.V.).
19. Green Lane Cardiovascular Services Auckland City Hospital, New Zealand (H.D.W.).
20. Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).
21. Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.).